Hetzel, Sara http://orcid.org/0000-0002-4783-3814
Mattei, Alexandra L. http://orcid.org/0000-0003-1450-8924
Kretzmer, Helene
Qu, Chunxu
Chen, Xiang http://orcid.org/0000-0002-2499-8261
Fan, Yiping
Wu, Gang http://orcid.org/0000-0002-1678-5864
Roberts, Kathryn G. http://orcid.org/0000-0001-7626-4043
Luger, Selina
Litzow, Mark
Rowe, Jacob
Paietta, Elisabeth
Stock, Wendy
Mardis, Elaine R. http://orcid.org/0000-0002-5892-1553
Wilson, Richard K.
Downing, James R.
Mullighan, Charles G. http://orcid.org/0000-0002-1871-1850
Meissner, Alexander http://orcid.org/0000-0001-8646-7469
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA021765, R35 CA197695)
Max-Planck-Gesellschaft
Article History
Received: 18 May 2021
Accepted: 25 March 2022
First Online: 19 May 2022
Competing interests
: A.M. is co-inventor on a patent related to hypermethylated CGI targets in cancer. A.M. is a co-founder and scientific advisor of Harbinger Health. A.M. is part of the scientific advisory board of Zymo Research. The other authors declare no competing interests.